HDAC6-Mediated NLRP3 Inflammasome Activation Is Involved in Nickel Nanoparticle-Induced Pulmonary Inflammation and Fibrosis
- 29 April 2025
- journal article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 38 (5) , 877-891
Abstract
Nickel nanoparticles (Nano-Ni) are increasingly utilized in industrial and biomedical applications, drawing growing attention to their potential adverse health effects. Our previous studies have demonstrated that Nano-Ni exposure induces severe, widespread, and persistent pulmonary inflammation and fibrosis. However, the underlying mechanisms are still unclear. The NLRP3 inflammasome is a vital component of the innate immune system and inflammatory signaling. In this study, we investigated whether Nano-Ni exposure activated the NLRP3 inflammasome and also examined its role in Nano-Ni-induced pulmonary inflammation and fibrosis. Our findings demonstrated that intratracheal instillation of wild-type mice (C57BL/6J) with 50 μg Nano-Ni per mouse resulted in NLRP3 inflammasome activation, IL-1β production, and extensive pulmonary inflammation and fibrosis. In contrast, Nano-Ni exposure induced only mild pulmonary inflammation and fibrosis in Nlrp3-/- mice (lacking functional NLRP3 inflammasome) or Il-1r1-/- mice (unresponsive to IL-1), highlighting the critical role of NLRP3 inflammasome activation in Nano-Ni-induced pulmonary damage. Further investigations using mouse alveolar macrophages (MH-S) revealed that Nano-Ni acts as a secondary activation signal for the NLRP3 inflammasome, triggering its activation in LPS-primed but not unprimed cells. Moreover, siRNA-mediated knockdown experiments demonstrated that this activation depended on Nano-Ni-induced upregulation of HDAC6. These findings suggest that Nano-Ni activates the NLRP3 inflammasome via HDAC6 as a second activation signal, leading to IL-1β production and subsequent pulmonary inflammation and fibrosis.Keywords
Funding Information
- National Institute of Environmental Health Sciences (ES023693, ES028911, P30 ES030283)
- National Heart, Lung, and Blood Institute (HL147856)
- Kentucky Science and Engineering Foundation (KSEF-148-RED-502-16-381)
- Kentucky Lung Cancer Research Program
This publication has 63 references indexed in Scilit:
- Resveratrol protects human bronchial epithelial cells against nickel‐induced toxicity via suppressing p38 MAPK, NF‐κB signaling, and NLRP3 inflammasome activationEnvironmental Toxicology, 2020
- Analysis of Nanomaterial Toxicity by Western Blot2018
- Genotoxic and mutagenic properties of Ni and NiO nanoparticles investigated by comet assay, γ‐H2AX staining, Hprt mutation assay and ToxTracker reporter cell linesEnvironmental and Molecular Mutagenesis, 2017
- Effects of urban particulate matter with high glucose on human monocytes U937Journal of Applied Toxicology, 2015
- Occupational handling of nickel nanoparticles: A case reportAmerican Journal of Industrial Medicine, 2014
- Pulmonary and systemic toxicity following exposure to nickel nanoparticlesAmerican Journal of Industrial Medicine, 2010
- Mediation of interleukin‐1β–induced transforming growth factor β1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: Possible cooperation with activator protein 1Arthritis & Rheumatism, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Particle Clearance and Histopathology in Lungs of F344/N Rats and B6C3F1 Mice Inhaling Nickel Oxide or Nickel SulfateFundamental and Applied Toxicology, 1995
- Interleukin-1β (IL-1β) Induces Transforming Growth Factor-β1 (TGF-β1) Production by Rat Aortic Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1994